Invention Grant
US09301947B2 Ryanodine receptor inhibitors for treatment of T-cell mediated disorders
有权
用于治疗T细胞介导的疾病的雷诺定受体抑制剂
- Patent Title: Ryanodine receptor inhibitors for treatment of T-cell mediated disorders
- Patent Title (中): 用于治疗T细胞介导的疾病的雷诺定受体抑制剂
-
Application No.: US14157333Application Date: 2014-01-16
-
Publication No.: US09301947B2Publication Date: 2016-04-05
- Inventor: Alla F. Fomina
- Applicant: The Regents of the University of California
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K31/40
- IPC: A61K31/40 ; A61K31/34 ; A61K31/4178 ; A61K31/4025 ; A61K45/06 ; A61K31/422

Abstract:
This invention relates to methods of treating T-cell mediated diseases or disorders in human or animal subjects, such as autoimmune diseases and chronic graft versus host disease in humans and animals. In particular, the methods comprise administering to the human or animal patient a pharmaceutical composition comprising a ryanodine receptor inhibitor.
Public/Granted literature
- US20140135385A1 RYANODINE RECEPTOR INHIBITORS FOR TREATMENT OF T-CELL MEDIATED DISORDERS Public/Granted day:2014-05-15
Information query